Harrall

United Kingdom
|
2021-2025
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Petersen

Faroe Islands
|
2022-2022
  • Adults
  • Elderly
  • Paediatric
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Andreasson

Sweden
|
2021-2025
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample

UKILD-Long COVID

United Kingdom
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

IMP@LA

France
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

LCV

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

OpenPROMPT

United Kingdom
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19

HemCOV

Sweden
|
2022-2037
  • Adults
  • General population
  • Community
  • SARS-CoV-2
  • Post-COVID-19

EuCARE-SCHOOLS

Italy Portugal Mexico
|
2022-2024
  • Adults
  • Paediatric
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Nasopharyngeal swab
  • Non pharmacological intervention

Paraskevis

Greece
|
2022-2022
  • Elderly
  • Fragile population
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Cuadrado-Payán

Spain
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Pereta

Spain
|
2020-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir